{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibywngqmewtvmtbnyqduvp7xazji3bcqhj4nkj3ylkawjgfyqcjpq",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mf4sdckpmyb2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreigxlj3c5h3lc3lm5ampjclcam3gwumw5gjluzvjvc5ar5isxx76mq"
    },
    "mimeType": "image/jpeg",
    "size": 100650
  },
  "path": "/2026/02/18/moderna-mrna-flu-vaccine-trust-regulatory-uncertainty/?utm_campaign=rss",
  "publishedAt": "2026-02-18T09:30:00.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "First Opinion",
    "Pharma",
    "Moderna",
    "Pharmaceuticals",
    "Policy",
    "public health",
    "Vaccines"
  ],
  "textContent": "“The pharmaceutical industry is not the enemy,” writes Richard Hughes IV, who was Moderna’s VP for public policy when the Covid vaccine rolled out.",
  "title": "Opinion: I was a Moderna exec when the Covid vaccine rolled out. That spirit of possibility is no more",
  "updatedAt": "2026-02-17T22:52:48.000Z"
}